A twist for survival and cancer progression

A major obstacle to the expansion of abnormal cells with significant proliferative potential is the induction of programmed cell death. Consequently, oncogene-driven hyperproliferation must be associated with apoptosis inhibition to allow malignant outgrowth. The oncogenic cooperation of N-Myc and Twist-1 in the development of neuroblastoma, the most common and deadly solid tumour of childhood, perfectly illustrates such a process. N-Myc promotes cell proliferation, whereas Twist-1 counteracts its pro-apoptotic properties by knocking-down the ARF/p53 pathway. On the basis of numerous recent studies reporting its overexpression in a variety of human cancers, we discuss in this review the role of Twist-1 as a potent inhibitor of the cell safety programs engaged in response to an abnormal mitogenic activity.

[1]  R. Gorlin,et al.  The Saethre-Chotzen syndrome. , 1975, Birth defects original article series.

[2]  B. Thisse,et al.  The twist gene: isolation of a Drosophila zygotic gene necessary for the establishment of dorsoventral pattern. , 1987, Nucleic acids research.

[3]  M. Leptin.  twist and snail as positive and negative regulators during Drosophila mesoderm development. , 1991, Genes & development.

[4]  W. Fiers,et al.  Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role , 1991, Cell.

[5]  Gerard I. Evan,et al.  Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.

[6]  M. Levine,et al.  The dorsal gradient morphogen regulates stripes of rhomboid expression in the presumptive neuroectoderm of the Drosophila embryo. , 1992, Genes & development.

[7]  Y. Jan,et al.  Functional gene cassettes in development. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Pelletier,et al.  Absence of p53 gene mutations in primary neuroblastomas. , 1993, Cancer research.

[9]  R. Winter,et al.  Saethre-Chotzen syndrome. , 1994, Journal of medical genetics.

[10]  R. Behringer,et al.  twist is required in head mesenchyme for cranial neural tube morphogenesis. , 1995, Genes & development.

[11]  E. Olson,et al.  Dermo-1: a novel twist-related bHLH protein expressed in the developing dermis. , 1995, Developmental biology.

[12]  S. Lowe,et al.  p53 modulation of anchorage independent growth and experimental metastasis. , 1996, Oncogene.

[13]  M. Takeichi,et al.  Dynamic behavior of the cadherin-based cell-cell adhesion system during Drosophila gastrulation. , 1998, Developmental biology.

[14]  J L Cleveland,et al.  Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. , 1998, Genes & development.

[15]  L. Kedes,et al.  Twist is a potential oncogene that inhibits apoptosis. , 1999, Genes & development.

[16]  L. Kedes,et al.  Regulation of Histone Acetyltransferases p300 and PCAF by the bHLH Protein Twist and Adenoviral Oncoprotein E1A , 1999, Cell.

[17]  S. Hellman,et al.  Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin. , 2000, Cancer research.

[18]  D. Leroith,et al.  Insulin-like Growth Factor 1 (IGF-1)-induced Twist Expression Is Involved in the Anti-apoptotic Effects of the IGF-1 Receptor* , 2001, The Journal of Biological Chemistry.

[19]  R. Roberto,et al.  Proliferate and survive: cell division cycle and apoptosis in human neuroblastoma. , 2002, Haematologica.

[20]  Birgit Luber,et al.  Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. , 2002, The American journal of pathology.

[21]  S. Lowe,et al.  Dissecting p53 tumor suppressor functions in vivo. , 2002, Cancer cell.

[22]  L. R. Howe,et al.  Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation. , 2003, Cancer research.

[23]  G. Brodeur.  Neuroblastoma: biological insights into a clinical enigma , 2003, Nature Reviews Cancer.

[24]  E. Olson,et al.  Twist Regulates Cytokine Gene Expression through a Negative Feedback Loop that Represses NF-κB Activity , 2003, Cell.

[25]  S. Iseki,et al.  DNazyme-mediated cleavage of Twist transcripts and increase in cellular apoptosis. , 2003, Biochemical and biophysical research communications.

[26]  A. Puisieux,et al.  Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells. , 2004, Cancer cell.

[27]  S. Ramaswamy,et al.  Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.

[28]  R. Willemze,et al.  Aberrant Expression of the Tyrosine Kinase Receptor EphA4 and the Transcription Factor Twist in Sézary Syndrome Identified by Gene Expression Analysis , 2004, Cancer Research.

[29]  L. Derycke,et al.  N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling. , 2004, The International journal of developmental biology.

[30]  S. Ariyan,et al.  Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. , 2004, Cancer research.

[31]  H. Cheung,et al.  Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells , 2004, Oncogene.

[32]  O. Watanabe,et al.  Expression of twist and wnt in human breast cancer. , 2004, Anticancer research.

[33]  M. Justice,et al.  A twist code determines the onset of osteoblast differentiation. , 2004, Developmental cell.

[34]  M. Gaub,et al.  Frequent genomic abnormalities at TWIST in human pediatric osteosarcomas , 2005, International journal of cancer.

[35]  Xiaomeng Zhang,et al.  Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. , 2005, Cancer research.

[36]  G. Watkins,et al.  Expression of the Transcription Factors Snail, Slug, and Twist and Their Clinical Significance in Human Breast Cancer , 2005, Annals of Surgical Oncology.

[37]  D. Tarin,et al.  Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? , 2005, Cancer research.

[38]  M. Grever,et al.  TWIST2 demonstrates differential methylation in immunoglobulin variable heavy chain mutated and unmutated chronic lymphocytic leukemia. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  H. Beug,et al.  Molecular requirements for epithelial-mesenchymal transition during tumor progression. , 2005, Current opinion in cell biology.

[40]  D. Tarin,et al.  The fallacy of epithelial mesenchymal transition in neoplasia. , 2005, Cancer research.

[41]  V. Raman,et al.  HOXA5-Twist Interaction Alters p53 Homeostasis in Breast Cancer Cells* , 2005, Journal of Biological Chemistry.